Three-times daily ultrafractionated radiation therapy, a novel and promising regimen for glioblastoma patients.
Fiche publication
Date publication
janvier 2013
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BEAUCHESNE Patrick
Tous les auteurs :
Beauchesne P
Lien Pubmed
Résumé
Glioblastomas are considered to be one of the most radio resistant tumors. Despite new therapies, the prognosis of this disease remains dismal. Also, the mechanisms of radiation resistance in mammalian cells are more complex than once believed. Experimental studies have indicated that some human cell lines are sensitive to low radiation doses of
Référence
Cancers (Basel). 2013 Sep 25;5(4):1199-211